Bacil Pharma Plans ₹50 Cr Rights Issue

Bacil Pharma Ltd has announced a board meeting scheduled for July 9, 2026, to consider a proposal for raising funds up to ₹50 crore through a Rights Issue of equity shares. The company also plans to discuss increasing its authorized share capital, altering the Memorandum of Association, and approving the terms of the Rights Issue. Additionally, the board will discuss director appointments and resignations. The trading window will remain closed for designated persons until 48 hours after the meeting's outcome is declared.